News BMS bolts on SystImmune bispecific ADC in $8.4bn deal The litany of big-ticket deals involving antibody-drug conjugates shows no sign of ending.
News RIF job losses are underway at HHS agencies; reports Reduction in force (RIF) job losses have started in earnest at US federal agencies, including the FDA and CDC, according to media reports.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
